Aurora Cannabis Closes $23 Million Financing and Signs Definitive Agreement to Acquire CanvasRx

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$229/ year*
Daily Morning INK newsletter
+1 year archive
Canadian Market INK weekly newsletter
+1 year archive
3 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
30-day money back guarantee*
JOIN THE CLUB
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
30-day money back guarantee*
GO AD-FREE

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you cancel with-in 30 days of first subscribing, we will refund your payment upon request. After cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

Aurora Cannabis Closes $23 Million Financing and Signs Definitive Agreement to Acquire CanvasRx

Canada NewsWire

/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/

CSE:ACB

VANCOUVER, Aug. 10, 2016 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (CSE: ACB) (OTCQB: ACBFF) (Frankfurt:  21P; WKN: A1C4WM) is pleased to announce, further to its news releases dated June 8, 2016 and July 18, 2016, that it has entered into a definitive share purchase agreement (the "Share Purchase Agreement") with CanvasRx Holdings Inc. (the "Vendor") to acquire (the "Acquisition") all of the issued and outstanding shares of CanvasRx Inc. ("CanvasRx").  In connection with the Acquisition, the Company has completed the brokered private placement of subscription receipts (the "Subscription Receipts") of the Company with Canaccord Genuity Corp. (the "Agent") as well as a concurrent non brokered private placement of Subscription Receipts for aggregate gross proceeds of $23 million (together, the "Offering").

The Share Purchase Agreement provides that the Company will acquire all of the issued and outstanding shares of CanvasRx in consideration for payments up to a maximum of $37,500,000, the majority of which consideration may be satisfied, at the election of the Company, in cash or through the issuance of shares of Aurora, as determined at Aurora's discretion. The total consideration is subject to the achievement of all specified performance milestones over a three-year period. The Acquisition, which is expected to close shortly, will unite Aurora, one of Canada's largest capacity and fastest-growing licensed producers of cannabis, with CanvasRx, Canada's largest medical cannabis patient outreach service, which has 17 locations and has registered more than 10,000 patients.

Pursuant to the Offering, the Company issued a total of 57,500,000 Subscription Receipts. Each Subscription will convert without payment of any additional consideration and with no further action required by the subscribers, upon the satisfaction of certain escrow release conditions (the "Escrow Release Conditions"), including satisfaction of the conditions precedent to the Acquisition (other than the payment of the purchase price), into units.  Each unit is comprised of one common share of the Company (a "Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Share at an exercise price of $0.55 per Share at any time up to August 9, 2018.

"This financing and acquisition provide Aurora with the capital and the partner to continue to responsibly expand our position in the cannabis sector," said Terry Booth, CEO. "With our industry-leading product quality and patient acquisition rate, our innovative use of technology and ultra-low cost of production, as well as our immediate plans for significant capacity expansion, Aurora is ideally placed to thrive in both the medical cannabis business and the eventual adult consumer cannabis market."

The Company intends to use the net proceeds of the Offering, which will be released from escrow to the Company upon satisfaction of the Escrow Release Conditions, to satisfy the cash component of the Acquisition and to fund a major expansion of Aurora's production capacity. Plans are well advanced for the construction of a second much larger production facility in Alberta, Canada.

All securities issued in connection with the Offering are subject to a four month hold period expiring December 10, 2016. 

On behalf of the Board of Directors,
AURORA CANNABIS INC.

Terry Booth
CEO

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.

SOURCE Aurora Cannabis Inc.

Copyright CNW Group 2016

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).